Med BioGene Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced net loss was USD 9,082 compared to USD 19,708 a year ago. For the nine months, net loss was USD 42,512 compared to USD 60,196 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.